Twenty-seven states and the District of Columbia have sued the bankrupt genetic testing company 23andMe in an effort to block ...

States argue that biological samples, DNA data, health-related traits and medical records are too sensitive to be sold ...

Twenty-eight states argue that 23andMe must secure explicit, informed consent from all 15 million affected users before ...

New York and more than two dozen other US states sued 23andMe to challenge the sale of its customers’ private information after the genetic testing company filed for bankruptcy in March.

More than two dozen states, along with the District of Columbia, are suing biotechnology company 23andMe over plans to ...

Twenty-seven states and Washington, D.C., have filed a lawsuit to block the sale of customers’ DNA and data without their ...

The possible sale of 23andMe’s genetic data could set a precedent for future cases where companies look to offload ...

People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest ...

D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces ...

States sue to halt Regeneron's 23andMe acquisition, citing privacy concerns over user DNA data, as a court-ordered report on ...

The California-based company, which allowed customers to learn about their ancestry by submitting saliva samples in the mail, ...